Get the Stockscreener App
8.30
4.49%
-0.39
After Hours:
8.16
-0.14
-1.69%
Quantum Biopharma Ltd stock is traded at $8.30, with a volume of 64,044.
It is down -4.49% in the last 24 hours and down -27.26% over the past month.
Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.
See More
Previous Close:
$8.69
Open:
$8.62
24h Volume:
64,044
Relative Volume:
0.44
Market Cap:
$31.90M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-6.64%
1M Performance:
-27.26%
6M Performance:
-21.40%
1Y Performance:
+375.64%
1-Day Range:
$8.0288
$8.9999
1-Week Range:
$8.0288
$11.49
52-Week Range:
$1.445
$19.12
Quantum Biopharma Ltd Stock (QNTM) Company Profile
Compare QNTM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QNTM
Quantum Biopharma Ltd
|
8.30 | 33.40M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.90 | 117.47B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.97 | 82.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.59 | 52.94B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
844.92 | 52.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.88 | 37.84B | 447.02M | -1.18B | -906.14M | -6.1812 |
Quantum Biopharma Ltd Stock (QNTM) Latest News
QNTM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm - The Malaysian Reserve
QNTM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma - GlobeNewswire
QNTM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares - The News-Press
Quantum BioPharma completes 180-day toxicity dosing for lead MS drug Lucid-MS - MSN
Quantum BioPharma completes oral dosing in key MS drug studies By Investing.com - Investing.com Nigeria
QNTM STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Quantum Biopharma Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Cannabis Stocks To Follow TodayDecember 11th - MarketBeat
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Completes 180-Day Toxicity Studies for Lucid-MS - FinancialContent
Grant & Eisenhofer Files Securities Class Action Lawsuit Against Canadian Imperial Bank of Commerce and Royal Bank of Canada on behalf of investors in Quantum Biopharma Ltd. Securities - FinancialContent
Quantum BioPharma : World Renowned Lаw Firm Grаnt & Eisenhofer Files Clаss Action Lаwsuit Against Canadian Banks CIBC and RBC Alleging Illegаl Stock Market Mаnipulation of Quantum BioPharma Shares - marketscreener.com
Quantum BioPharma Completes Dosing For 180-day Lucid-MS Studies - marketscreener.com
Quantum BioPharma Completes 180-Day Toxicity Dosing for Lead MS Drug Lucid-MS - TipRanks
Quantum BioPharma completes oral dosing in key MS drug studies - Investing.com
Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS) - The Manila Times
Quantum shareholder files class action lawsuit against the company - MSN
Quantum BioPharma Launches US$17.2 Million ATM Equity Program on Nasdaq - TipRanks
Quantum BioPharma Moves to Lead Class Action Alleging Bank Manipulation of Its Shares - TipRanks
World Renowned Law Firm Grant & Eisenhofer Files Class - GlobeNewswire
Why Quantum BioPharma Ltd. stock is a must watch in 2025Market Activity Report & Precise Swing Trade Alerts - moha.gov.vn
How Quantum BioPharma Ltd. stock reacts to global recession fearsEarnings Risk Summary & Accurate Entry/Exit Alerts - Улправда
Will Quantum BioPharma Ltd. stock attract ESG investorsGap Up & Reliable Volume Spike Alerts - ulpravda.ru
Quantum BioPharma Moves to Lead Class Action Over Alleged Stock Manipulation by Canadian Banks - TipRanks
VIX Spike: How Quantum BioPharma Ltd. stock reacts to global recession fearsMarket Activity Summary & Free Long-Term Investment Growth Plans - Улправда
Is Quantum BioPharma Ltd. (0K91) stock dividend growth reliableMarket Risk Report & High Accuracy Trade Alerts - Улправда
Quantum BioPharma (XCNQ:QNTM) EV-to-OCF : -3.86 (As of Dec. 19, 2025) - GuruFocus
Can Quantum BioPharma Ltd. stock sustain market leadership2025 Earnings Impact & Capital Efficient Trade Techniques - DonanımHaber
Quantum BioPharma (STU:0K91) EV-to-OCF : -3.48 (As of Dec. 18, 2025) - GuruFocus
Quantum BioPharma (STU:0K91) EV-to-FCF : -3.46 (As of Dec. 17, 2025) - GuruFocus
Quantum Biopharma Ltd Stock (QNTM) Financials Data
There is no financial data for Quantum Biopharma Ltd (QNTM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.08%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):